| Old Articles: <Older 42821-42830 Newer> |
|---|
 |
The Motley Fool
August 4, 2010
Matt Koppenheffer |
How Much Is Abbott Labs Worth? Is Abbott Labs' stock on sale?   |
The Motley Fool
August 4, 2010
Seth Jayson |
Show Me the Money, Dolby Laboratories All cash flow is not created equal. |
The Motley Fool
August 4, 2010
Mac Greer |
One Biotech Stock Ready to Rebound? One of our analysts gives you his thoughts on Elan. |
The Motley Fool
August 4, 2010
Rex Moore |
The 15 Best Values in Health Care Low multiples plus low risk equals compelling value. |
The Motley Fool
August 4, 2010
Seth Jayson |
Show Me the Money, Buckle All cash flow is not created equal in retail stocks. |
The Motley Fool
August 4, 2010
Luke Timmerman |
Dendreon Conference Call Notebook: The Tale of a Provenge Launch Ramp-Up What's working for Dendreon? How is its groundbreaking prostate cancer drug performing in its first few months on the market? |
The Motley Fool
August 4, 2010
Ryan McBride |
How Eli Lilly Let a Billion-Dollar Molecule Slip Away, and Make a Fortune for Vertex The remains of Lilly's partnership with Vertex Pharmaceuticals. |
The Motley Fool
August 4, 2010
Anders Bylund |
What Is STEC Hiding? Why is solid-state storage specialist STEC playing its cards so close to the vest? Does the company have anything to hide? |
The Motley Fool
August 4, 2010
Rich Smith |
This Just In: Upgrades and Downgrades UBS takes on Applied Materials. |
The Motley Fool
August 4, 2010
Anders Bylund |
A Growth Stock Poised to Wake Up Don't let Sonus trick you with a weak pulse -- this is a growth stock, playing possum. |
| <Older 42821-42830 Newer> Return to current articles. |
